Introduction:Basic information about CAS 84676-89-1|Astragaloside II, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Astragaloside II |
|---|
| CAS Number | 84676-89-1 | Molecular Weight | 827.01 |
|---|
| Density | 1.4±0.1 g/cm3 | Boiling Point | 896.9±65.0 °C at 760 mmHg |
|---|
| Molecular Formula | C43H70O15 | Melting Point | / |
|---|
| MSDS | ChineseUSA | Flash Point | 265.3±27.8 °C |
|---|
Names
| Name | Astragaloside II |
|---|
| Synonym | More Synonyms |
|---|
Astragaloside II BiologicalActivity
| Description | Astragaloside II is a natural isolated from Astragalus.IC50 value:Target:In vitro:In vivo: The developed and validated method has been successfully applied to the quantification and pharmacokinetic study of AST II in rats after intravenous and oral administration of AST II. The oral absolute bioavailability (F) of AST II was calculated to be 0.79 ± 0.16% with an elimination half-life (t1/2) value of 1.92 ± 0.30 h, suggesting its poor absorption and/or strong metabolism in vivo [1]. |
|---|
| Related Catalog | Signaling Pathways >>Others >>OthersResearch Areas >>OthersNatural Products >>Terpenoids and Glycosides |
|---|
| References | [1]. Haijun Qu, et al. Quantification and pharmacokinetics of astragaloside II in rats by rapid liquid chromatography-tandem mass spectrometry. Anal. Methods, 2014,6, 6815-6822 [2]. Kong XH, et al. Astragaloside II induces osteogenic activities of osteoblasts through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways. Int J Mol Med. 2012 Jun;29(6):1090-8. [3]. Huang C, et al. Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II. J Pharm Pharmacol. 2012 Dec;64(12):1741-50. [4]. Wan CP, et al. Astragaloside II triggers T cell activation through regulation of CD45 protein tyrosine phosphatase activity. Acta Pharmacol Sin. 2013 Apr;34(4):522-30. |
|---|
Chemical & Physical Properties
| Density | 1.4±0.1 g/cm3 |
|---|
| Boiling Point | 896.9±65.0 °C at 760 mmHg |
|---|
| Molecular Formula | C43H70O15 |
|---|
| Molecular Weight | 827.01 |
|---|
| Flash Point | 265.3±27.8 °C |
|---|
| PSA | 234.29000 |
|---|
| LogP | 0.80 |
|---|
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
|---|
| Index of Refraction | 1.615 |
|---|
| InChIKey | AYWNHWGQTMCQIV-RHKAXKFRSA-N |
|---|
| SMILES | CC(=O)OC1C(OC2CCC34CC35CCC3(C)C(C6(C)CCC(C(C)(C)O)O6)C(O)CC3(C)C5CC(OC3OC(CO)C(O)C(O)C3O)C4C2(C)C)OCC(O)C1O |
|---|
Safety Information
| Hazard Codes | Xi |
|---|
| RIDADR | NONH for all modes of transport |
|---|
| HS Code | 29389090 |
|---|
Synonyms
| β-D-Glucopyranoside, (3β,6α,16β,20R,24S)-3-[(2-O-acetyl-β-D-xylopyranosyl)oxy]-20,24-epoxy-16,25-dihydroxy-14-methyl-9,19-cyclocholestan-6-yl |
| Cyclosieversioside D |
| (3β,6α,16β,20R,24S)-3-[(2-O-Acetyl-β-D-xylopyranosyl)oxy]-16,25-dihydroxy-14-methyl-20,24-epoxy-9,19-cyclocholestan-6-yl β-D-glucopyranoside |
| AstrasieversianinVIII |
| 16,25-dihydroxy-9,19-cyclolanostan-6-yl |
| Astragaloside B |
| Cyclosiversioside D |